Letter: 5-aminosalicylate maintenance treatment in mild Crohn's disease-authors' reply

被引：0
|
作者：
Atia, Ohad [1 ]
Goren, Idan [2 ,3 ,4 ]
Yanai, Henit [2 ,3 ]
机构：
[1] Hebrew Univ Jerusalem, Juliet Keidan Inst Pediat Gastroenterol Hepatol &, Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Rabin Med Ctr, Div Gastroenterol, Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[4] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH USA
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 57卷 / 10期
关键词：
D O I：
10.1111/apt.17504
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1184 / 1185
页数：2
相关论文
共 50 条
  • [21] accuracy of magnetic resonance index of activity score to predict response to biologics in Crohn's disease-authors' reply
    Rimola, Jordi
    Panes, Julian
    Ordas, Ingrid
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (01) : 207 - 208
  • [22] Letter: comedication use and dementia risk in patients with inflammatory bowel disease-authors' reply
    Ronnow Sand, Jakob
    Troelsen, Frederikke Schonfeldt
    Horvath-Puho, Erzsebet
    Henderson, Victor W.
    Sorensen, Henrik Toft
    Erichsen, Rune
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (10) : 1505 - 1506
  • [23] Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply
    Hadi, Yousaf
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1228 - 1229
  • [24] Letter: the effect of anti-COVID-19 treatment on the outcome of patients with inflammatory bowel disease-authors' reply
    Hadi, Yousaf
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (01) : 179 - 179
  • [25] Letter: The Prognostic Role of IGF-1 in Chronic Liver Disease-Authors' Reply
    Hartl, Lukas
    Schwarz, Michael
    Simbrunner, Benedikt
    Jachs, Mathias
    Wolf, Peter
    Bauer, David Josef Maria
    Scheiner, Bernhard
    Balcar, Lorenz
    Semmler, Georg
    Hofer, Benedikt Silvester
    Dominik, Nina
    Marculescu, Rodrig
    Trauner, Michael
    Mandorfer, Mattias
    Reiberger, Thomas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 228 - 229
  • [26] Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' reply
    Takenaka, Kento
    Kawamoto, Ami
    Ohtsuka, Kazuo
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (08) : 1087 - 1087
  • [27] Letter: stool adalimumab detection in ulcerative colitis and Crohn's disease - authors' reply
    Rosen, M. J.
    Minar, P.
    Vinks, A. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (02) : 241 - 241
  • [28] Letter: endoscopic balloon dilatation or strictureplasty for stricturing Crohn's disease? Authors' reply
    Gustavsson, A.
    Blomberg, B.
    Andersson, M.
    Halfvarson, J.
    Tysk, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (04) : 404 - 404
  • [29] Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy
    Campbell, S
    Ghosh, S
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2001, 13 (11) : 1297 - 1301
  • [30] Letter: proving the benefit of exercise intervention in metabolic associated fatty liver disease-authors' reply
    O'Gorman, Philip
    Naimimohasses, Sara
    Monaghan, Ann
    Kennedy, Megan
    Finn, Stephen P.
    Moore, J. Bernadette
    Gormley, John
    Norris, Suzanne
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (08) : 1426 - 1427
12345